Victory Capital Management Inc. Grows Stake in Addus HomeCare Co. (NASDAQ:ADUS)

Victory Capital Management Inc. raised its stake in Addus HomeCare Co. (NASDAQ:ADUS) by 6.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 84,960 shares of the company’s stock after purchasing an additional 4,913 shares during the quarter. Victory Capital Management Inc. owned about 0.47% of Addus HomeCare worth $11,302,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the stock. Texas Permanent School Fund Corp raised its position in Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after purchasing an additional 82 shares during the period. Arizona State Retirement System increased its position in shares of Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock worth $527,000 after acquiring an additional 87 shares during the last quarter. UMB Bank n.a. increased its position in shares of Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the last quarter. Inspire Investing LLC increased its position in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after acquiring an additional 100 shares during the last quarter. Finally, New York State Teachers Retirement System increased its position in shares of Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after acquiring an additional 100 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $120.99 on Thursday. Addus HomeCare Co. has a one year low of $85.43 and a one year high of $136.12. The stock has a fifty day moving average of $128.52 and a 200-day moving average of $122.88. The company has a market capitalization of $2.19 billion, a PE ratio of 27.69, a price-to-earnings-growth ratio of 2.09 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.03 EPS. As a group, research analysts forecast that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Insider Activity

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares in the company, valued at $429,165. This represents a 12.93 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. The trade was a 75.23 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock worth $3,050,082 over the last quarter. Corporate insiders own 4.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Stephens lifted their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Oppenheimer lifted their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Macquarie reaffirmed an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp started coverage on Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Finally, TD Cowen upped their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. One analyst has rated the stock with a sell rating, eight have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Addus HomeCare currently has an average rating of “Moderate Buy” and a consensus price target of $131.63.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.